192 related articles for article (PubMed ID: 27227676)
1. Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein Function.
Tajnik M; Rogalska ME; Bussani E; Barbon E; Balestra D; Pinotti M; Pagani F
PLoS Genet; 2016 May; 12(5):e1006082. PubMed ID: 27227676
[TBL] [Abstract][Full Text] [Related]
2. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
[TBL] [Abstract][Full Text] [Related]
3. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
[TBL] [Abstract][Full Text] [Related]
4. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
[TBL] [Abstract][Full Text] [Related]
5. Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants.
Katneni UK; Liss A; Holcomb D; Katagiri NH; Hunt R; Bar H; Ismail A; Komar AA; Kimchi-Sarfaty C
Mol Genet Genomic Med; 2019 Aug; 7(8):e840. PubMed ID: 31257730
[TBL] [Abstract][Full Text] [Related]
6. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.
Fernandez Alanis E; Pinotti M; Dal Mas A; Balestra D; Cavallari N; Rogalska ME; Bernardi F; Pagani F
Hum Mol Genet; 2012 Jun; 21(11):2389-98. PubMed ID: 22362925
[TBL] [Abstract][Full Text] [Related]
7. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
[TBL] [Abstract][Full Text] [Related]
8. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.
Liang Y; Tebaldi T; Rejeski K; Joshi P; Stefani G; Taylor A; Song Y; Vasic R; Maziarz J; Balasubramanian K; Ardasheva A; Ding A; Quattrone A; Halene S
Leukemia; 2018 Dec; 32(12):2659-2671. PubMed ID: 29858584
[TBL] [Abstract][Full Text] [Related]
9. Splicing defects caused by exonic mutations in PKD1 as a new mechanism of pathogenesis in autosomal dominant polycystic kidney disease.
Claverie-Martin F; Gonzalez-Paredes FJ; Ramos-Trujillo E
RNA Biol; 2015; 12(4):369-74. PubMed ID: 25757501
[TBL] [Abstract][Full Text] [Related]
10. Exonic splicing enhancers contribute to the use of both 3' and 5' splice site usage of rat beta-tropomyosin pre-mRNA.
Selvakumar M; Helfman DM
RNA; 1999 Mar; 5(3):378-94. PubMed ID: 10094307
[TBL] [Abstract][Full Text] [Related]
11. Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.
Odaira K; Tamura S; Suzuki N; Kakihara M; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Okamoto S; Suzuki A; Kanematsu T; Matsushita T; Kojima T
Thromb Res; 2019 Jul; 179():95-103. PubMed ID: 31102861
[TBL] [Abstract][Full Text] [Related]
12. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.
Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M
Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760
[TBL] [Abstract][Full Text] [Related]
13. Binding of SRSF4 to a novel enhancer modulates splicing of exon 6 of Fas pre-mRNA.
Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Biochem Biophys Res Commun; 2018 Nov; 506(3):703-708. PubMed ID: 30376989
[TBL] [Abstract][Full Text] [Related]
14. TCIRG1-dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA.
Susani L; Pangrazio A; Sobacchi C; Taranta A; Mortier G; Savarirayan R; Villa A; Orchard P; Vezzoni P; Albertini A; Frattini A; Pagani F
Hum Mutat; 2004 Sep; 24(3):225-35. PubMed ID: 15300850
[TBL] [Abstract][Full Text] [Related]
15. In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects.
Lastella P; Surdo NC; Resta N; Guanti G; Stella A
BMC Genomics; 2006 Sep; 7():243. PubMed ID: 16995940
[TBL] [Abstract][Full Text] [Related]
16. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations.
Ketterling RP; Drost JB; Scaringe WA; Liao DZ; Liu JZ; Kasper CK; Sommer SS
Hum Mutat; 1999; 13(3):221-31. PubMed ID: 10090477
[TBL] [Abstract][Full Text] [Related]
17. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
[TBL] [Abstract][Full Text] [Related]
18. BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
Morrison A; Chekaluk Y; Bacares R; Ladanyi M; Zhang L
PLoS One; 2015; 10(4):e0119224. PubMed ID: 25830670
[TBL] [Abstract][Full Text] [Related]
19. Use of modified U1 small nuclear RNA for rescue from exon 7 skipping caused by 5'-splice site mutation of human cathepsin A gene.
Yamazaki N; Kanazawa K; Kimura M; Ike H; Shinomiya M; Tanaka S; Shinohara Y; Minakawa N; Itoh K; Takiguchi Y
Gene; 2018 Nov; 677():41-48. PubMed ID: 30010039
[TBL] [Abstract][Full Text] [Related]
20. A minimal length between tau exon 10 and 11 is required for correct splicing of exon 10.
Yu Q; Guo J; Zhou J
J Neurochem; 2004 Jul; 90(1):164-72. PubMed ID: 15198676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
